The Technical Analyst
Nobilis Health Corp. [HLTH]
Exchange: NYSE Sector: Healthcare Industry: Health Information Services
Nobilis Health Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.09% $0.141
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 22.35 mill |
| EPS: | -2.44 |
| P/E: | -0.0600 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 158.52 mill |
| Avg Daily Volume: | 0.508 mill |
| RATING 2024-04-26 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0600 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.02x |
| Company: PE -0.0600 | industry: PE 2.71 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.120 - 0.162 ( +/- 14.89%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-25 | Sever Clint | Sell | 20 456 | Common Stock |
| 2024-03-05 | Pollard Randall E. | Sell | 7 304 | Common Stock |
| 2024-03-05 | Achar Christopher K | Sell | 8 482 | Common Stock |
| 2024-03-05 | Javed Aasim | Sell | 13 327 | Common Stock |
| 2024-03-05 | Sever Clint | Sell | 12 604 | Common Stock |
| INSIDER POWER |
|---|
| 66.20 |
| Last 95 transactions |
| Buy: 4 908 639 | Sell: 1 235 305 |
Forecast:
16:00 - $0.141
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.141
Forecast 2: 16:00 - $0.141
Forecast 3: 16:00 - $0.141
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.141 (-3.09% ) |
| Volume | 0.437 mill |
| Avg. Vol. | 0.508 mill |
| % of Avg. Vol | 86.10 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HLTH
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HLTH
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Last 10 Buy Signals
Latest Press Releases
2024-03-20 17:21:00 - Press Release
Cue Health Announces Strategic Actions To Position Company For Next Stage
San diego--(business wire)--cue health inc. ("cue" or the “company”) (nasdaq: hlth), a healthcare technology company, today announced strategic actions implemented by its board of directors (the “board”) to best position the company for its next stage: clint sever, co-founder and current chief product officer, has been appointed ceo, effective immediately. sever succeeds ayub khattak, who is stepping down as chief executive officer, president, and chairman. khattak will remain a member of the b.
2024-03-13 16:01:00 - Press Release
Cue Health Reports Fourth Quarter 2023 Financial Results
San diego--(business wire)--cue health inc. ("cue" or the “company”) (nasdaq: hlth), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. recent highlights reported fourth quarter total revenue of $18.8 million. full-year 2023 total revenue was $70.9 million submitted additional clinical samples and stability data for rsv to the fda in support of de novo submission submitted additional clinical samples and gathering additional stability da.
2024-02-16 17:00:00 - Press Release
Cue Health Announces Appointment Of Rishi Reddy To Board Of Directors
San diego--(business wire)--cue health (nasdaq: hlth), a healthcare technology company, today announced it entered into a cooperation agreement (the “cooperation agreement”) with tarsadia investments (“tarsadia”), and appointed rishi reddy to its board of directors (the “board”), effective immediately. mr. reddy is a managing director at tarsadia, where he leads the firm's venture and growth equity strategy. he was previously an observer on cue's board of directors from april 2018 to september.
2024-01-31 16:01:00 - Press Release
Cue Health To Participate At The Btig Medtech, Digital Health, Life Science & Diagnostic Tools Conference
San diego--(business wire)--cue health (“cue”) (nasdaq: hlth), a healthcare technology company, announced today that its management team will participate at the btig medtech, digital health, life science & diagnostic tools conference on tuesday, february 13, 2024. about cue health cue health inc. (nasdaq: hlth) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. the cue health platform offers individuals and healthcare provid.
2023-11-08 16:01:00 - Press Release
Cue Health Reports Third Quarter 2023 Financial Results
San diego--(business wire)--cue health inc. ("cue") (nasdaq: hlth), a healthcare technology company, today reported financial results for the third quarter 2023. recent highlights reported third quarter total revenue of $17.5 million, approximately 50% above the midpoint of our guidance range of $11 to $13 million. three tests in review with the fda: cue® flu a/b + covid-19 multiplex molecular test emergency use authorization (eua) for at-home and point-of-care use. cue flu a/b molecular tests.
Latest News
2024-03-18 20:49:51 - InvestorPlace
3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter
Listen, if you haven't gotten the memo, penny stocks are incredibly dangerous. Yes, they're cheap – in this case, extremely cheap.
2024-03-13 18:10:16 - Zacks Investment Research
Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates
Cue Health Inc. (HLTH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago.
2023-11-08 23:43:10 - Seeking Alpha
Cue Health Inc. (HLTH) Q3 2023 Earnings Call Transcript
Cue Health Inc. (NASDAQ:HLTH ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Lorna Williams - Investor Relations Ayub Khattak - Chairman, President and Chief Executive Officer Aasim Javed - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Operator Good day and thank you for standing by. Welcome to the Cue Health Third Quarter 2023 Earnings Conference Call.
2023-10-25 16:01:00 - Business Wire
Cue Health to Announce Third Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. To access the live call via telephone, please register in advance using the link here. Upon reg.
2023-08-09 22:17:05 - Seeking Alpha
Cue Health Inc. (HLTH) Q2 2023 Earnings Call Transcript
Cue Health Inc. (NASDAQ:HLTH ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - CFO Conference Call Participants David Delahunt - Goldman Sachs Charles Rhyee - TD Cowen Operator Good day and thank you for standing by. Welcome to the Cue Health Second Quarter 2023 Earnings Conference Call.
2023-08-09 18:59:15 - Zacks Investment Research
Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates
Cue Health Inc. (HLTH) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.37 per share a year ago.
2023-06-06 15:32:08 - Reuters
US FDA approves Cue Health's at-home COVID test
The U.S. Food and Drug Administration on Tuesday approved Cue Health's at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency said.
2023-05-29 11:05:20 - Zacks Investment Research
Cue Health Inc. (HLTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Cue Health Inc. (HLTH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
2023-05-17 13:33:24 - Zacks Investment Research
Cue Health Inc. (HLTH) Upgraded to Buy: Here's What You Should Know
Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2023-05-17 11:17:06 - Zacks Investment Research
Cue Health Inc. (HLTH) Loses -47.82% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Cue Health Inc. (HLTH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.